ClinicalTrials.Veeva

Menu

Isolated Oligohydramnios Less Favorable Delivery and Neonatal Outcomes

Z

Zagazig University

Status

Completed

Conditions

Oligohydramnios, Delivered

Treatments

Behavioral: observation of delivery and neonatal outcomes

Study type

Observational

Funder types

Other

Identifiers

NCT05559957
AFHSRMREC/2020/OB/GYNAE/429

Details and patient eligibility

About

Oligohydramnios happens in 1-5% of term pregnancies. The clinical significance of isolated oligohydramnios been a matter of debate. We aimed in this study to investigate the impact of isolated oligohydramnios on the mode of delivery and risk of adverse perinatal outcome.

Full description

Retrospective study conducted in Armed Forces Hospitals of Southern Region, comparing cases with oligohydramnios (amniotic fluid level index <5) to normal amniotic fluid cases (amniotic fluid level index ≥ 8). Primary outcomes are the mode of delivery and adverse perinatal outcomes (including mortality, NICU admission, low Apgar score and sepsis)

Enrollment

636 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Third trimester pregnancy
  2. Isolated oligohydramnios

Exclusion criteria

  1. Multiple pregnancy
  2. less than 32 weeks
  3. medical disorders like DM HPN
  4. Fetal jeopardy

Trial design

636 participants in 2 patient groups

Isolated oligohydramnios group
Description:
Cases with oligohydramnios (amniotic fluid index less than 5) without an overt underlying reason in the third trimester
Treatment:
Behavioral: observation of delivery and neonatal outcomes
Normal amniotic fluid group
Description:
Normal pregnancy cases with normal amniotic fluid index
Treatment:
Behavioral: observation of delivery and neonatal outcomes

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems